key: cord-0967341-udsagyiz
authors: Prasad, Nikhil K.; Englum, Brian R.; Mayorga-Carlin, Minerva; Turner, Douglas J.; Sahoo, Shalini; Sorkin, John D.; Lal, Brajesh K.
title: Partial COVID-19 vaccination associated with reduction in postoperative mortality and SARS-CoV-2 infection
date: 2022-04-08
journal: Am J Surg
DOI: 10.1016/j.amjsurg.2022.03.038
sha: f2ab0b61c07bf61e0f60b7f627965d71b6951527
doc_id: 967341
cord_uid: udsagyiz

BACKGROUND: There are currently no data to guide decisions about delaying surgery to achieve full vaccination. METHODS: We analyzed data from patients undergoing surgery at any of the 1,283 VA medical facilities nationwide and compared postoperative complication rates by vaccination status. RESULTS: Of 87,073 surgical patients, 20% were fully vaccinated, 15% partially vaccinated, and 65% unvaccinated. Mortality was reduced in full vaccination vs. unvaccinated (Incidence Rate Ratio 0.77, 95% CI [0.62, 0.94]) and partially vaccinated vs. unvaccinated (0.75 [0.60, 0.94]). Postoperative COVID-19 infection was reduced in fully (0.18 [0.12, 0.26]) and partially vaccinated patients (0.34 [0.24, 0.48]). Fully vaccinated compared to partially vaccinated patients, had similar postoperative mortality (1.02, [0.78, 1.33]), but had decreased COVID-19 infection (0.53 [0.32, 0.87]), pneumonia (0.75 [0.62, 0.93]), and pulmonary failure (0.79 [0.68, 0.93]). CONCLUSIONS: Full and partial vaccination reduces postoperative complications indicating the importance of any degree of vaccination prior to surgery.

As of November 17, 2021, 58.9% of the population in the United States (US) was fully 2 vaccinated while an additional 9.8% was partially vaccinated against COVID-19, having 3 received only one of a two-dose vaccine. 1 Among vaccinated individuals in the US, vaccination 4 has significantly lowered COVID-19 infection rates and adverse outcomes compared to 5 unvaccinated individuals. 2 Real world data suggests that vaccination is associated with lower 6 rates of hospital admission and mortality for COVID-19. 3, 4 The Pfizer-BioNTech and Moderna 7 mRNA vaccines, both a two-dose regimen, were the first to gain FDA approval for use in the 8 US. 5 Based on antibody titres, the Centers for Disease Control and Prevention (CDC) have found 9 that maximum protection against COVID-19 develops two weeks after the second dose. 6 We 10 have previously shown data that mRNA vaccines against SARS-CoV-2 are associated with 11 reduced rates of postoperative COVID-19 and pulmonary complications. 7 However, there are no 12 data comparing the effectiveness of being fully vaccinated vs. partially vaccinated. Patients and 13

surgeons have no guidance on whether the risks associated with delaying surgical procedures are 14 outweighed by the benefits of waiting the recommended two weeks after the second dose of 15 vaccination to allow for maximum immune protection. This question is particularly important in 16 the context of elective and urgent procedures. We hypothesized that any degree of vaccination 17 would be protective against the known sequalae of COIVD-19 infection. We further 18 hypothesized that being fully vaccinated would offer more protection than being partially 19 vaccinated. 20

The Veterans' Health Administration (VA) provides care to more than nine million 21 individuals throughout the US. 8 We analyzed data from patients undergoing surgery (elective, 22 urgent, and emergency) at any of the 1,283 VA medical facilities nationwide and compared 23 J o u r n a l P r e -p r o o f as asymptotic COVID patients are presumably less likely to test. We also excluded patients when 1 data necessary for analysis was unknown, i.e., if they were missing data on race, BMI, CPT 2 code, case urgency, or anesthesia type. 3 4

Data were obtained from the VA Corporate Data Warehouse, VINCI (VA Informatics 6 and Computing Infrastructure), which stores all data entered into the VA's electronic medical 7 record, known as CPRS (Computerized Patient Record System). 9 The VA updates and 8 continuously checks the data for accuracy in near real time, and supplements CPRS with external 9 medical records whenever Veterans receive medical treatment outside the VA. Data obtained 10 described the patient, the vaccine, the surgery, and the postoperative outcome. Patient data 11 included age, sex, race (white, black, and other), ethnicity (Hispanic/Latino or not), body mass 12 index (BMI), smoking status (current, former, or never), the American Society of 13

Anesthesiologists (ASA) physical status classification 10 , and medical comorbidities, defined by 14 the International Classification of Disease 10th revision (ICD-10) codes. Pre-surgical 15 comorbidity was quantified by the Elixhauser comorbidity index (ECI), a composite of 30 16 comorbidities existing within two years of the date of surgery. 11 Higher ECI values indicate a 17 higher burden of comorbidities. Vaccine data included vaccine type and the date of 18 administration of each dose. Data describing the surgery included the five-digit Current 19

Procedural Terminology (CPT) code describing the procedure in its entirety, case urgency 20 (elective, urgent, or emergency), and type of anesthesia used (general or other, a composite of 21 sedation, spinal, epidural and local). The first two digits of the CPT code were then used to 22 describe the organ system undergoing surgery. discharge, outpatient, and transfer notes. ICD-10 and CPT codes were used to identify 10 mechanical ventilation. For all outcome measures, events that occurred more than 30 days after 11 the index procedure were ignored. 12 13

We compared the demographic, clinical, and procedural characteristics across the 15 vaccination groups (fully vaccinated, partially vaccinated, and unvaccinated) using frequencies 16 and percentages, means and standard deviations (SD), or medians and interquartile ranges (IQR), 17 as appropriate. Comparisons of categorical data were performed using Pearson's χ 2 test. 18

One-way analysis of variance (ANOVA) was used to compare normally distributed continuous 19 data across the three vaccination groups, and Kruskal-Wallis one-way analysis of variance by 20 rank (H test) was used for non-normally distributed continuous data. 21

Poisson regression was used to compare the postoperative complication rates in the three 22 vaccination groups. We used six distinct models, each one with one of our two primary or four 23 secondary outcome measures as the dependent variable. All models were adjusted for age, sex, 24 and fully vaccinated patients, unvaccinated patients were more likely to be obese (p<0.001). The 1 distribution of surgical procedures was similar in the three groups. (Supplementary Figure 1) particularly surgery that includes general anesthesia, is known to suppress innate immune 1 response to infective agents. Vaccination, by pre-conditioning the immune system to mount a 2 vigorous response to Sar-CoV-2, may offset some of the immune suppression brought about by 3 major surgery. Although full and partial vaccination may interact with these mechanisms in 4 different ways, our study suggests that vaccination status should be considered when determining 5 the timing of elective, and possibly urgent surgery. 6

We have previously reported significant elevations in mortality, reoperation, readmission, 7 and pulmonary complications among individuals who test positive for COVID-19 in the 8 postoperative period. 12 The reduction in postoperative COVID-19 infection shown in this report 9 may be responsible for the lower mortality rate after a single dose of mRNA vaccine. These 10 findings are corroborated by a recent report from the Israeli vaccination drive, in which a single 11 dose of vaccine was 72% effective at reducing mortality after two weeks. 3 those who had received their second dose at least two weeks prior to surgery) had the lowest 20 rates of pulmonary complications and COVID-19 infections. Partially vaccinated patients had 21 partial protection, with pulmonary complication rates that were higher than fully vaccinated 22 patients but lower than the unvaccinated. The higher incidence of pulmonary complications may 23 be direct sequelae of COVID-19 infection, or an indirect opportunistic infection after long-term 1 pulmonary damage from prior COVID-19. The dose response we found lends credibility to our 2 findings. It is, however, important to note that even a single dose of vaccine reduced the rate of 3 postoperative COVID-19 infection. This is in line with recent reports suggesting that, among 4 individuals who have previously been infected with COVID-19, a single dose of vaccine induces 5 a much stronger antibody response, and greater protection than those who have never been 6 exposed to the virus. 15-17 7

In addition to confirming our previous report, which noted that two doses of mRNA 8 vaccine were associated with a lower rate of pulmonary failure compared to no vaccination, 7 the 9 current report finds that being partially vaccinated is associated with reduction in the rates of 10 pulmonary failure. Given the reduction in mortality rates associated with being partially 11 vaccinated, it is possible that there are other systemic benefits to SARS-CoV-2 viral mRNA 12 exposure through vaccination. COVID-19 can produce a severe systemic inflammatory 13 response, 18,19 which may be mitigated in part by even a single dose of vaccine. 14 We attempted to provide detailed information on the decreasing risk of postoperative 15 complications as a function of time from initial vaccination dose to guide clinicians on when 16 surgery might be safest when a time-sensitive procedure does not allow the four weeks needed to 17 achieve full vaccination status. Unfortunately, limited numbers of events in these more granular 18 groups did not permit for robust comparisons, and we will have to wait for future studies to 19 provide insight on the benefits of waiting a specific number of weeks after initial vaccination to 20 proceed to surgery. 21

Our analysis has several limitations. First, we were not able to obtain the causes of death 22 in the patients we followed. This information might allow a better characterization of why 23 J o u r n a l P r e -p r o o f patients in the non-vaccinated group had a higher mortality rate, but it does not negate the 1 finding that full or partial vaccination status was associated with a reduction in all-cause 2 mortality in patients undergoing surgery. Our study is not intended to be construed as the 3 definitive body of work on this topic, however, the results can be used to guide future studies. 4

Our study is not a randomized clinical trial and as a result may be subject to unrecognized 5 residual bias despite our use of statistical adjustment to account for differences between our three 6 study groups. Concern about the potential presence of residual bias is applicable to every non-7 randomized observational study that has investigated the COVID-19 pandemic. Despite this 8 concern we believe that our study makes an important contribution to our understanding of a 9 disease that, given the known benefits of vaccination, precludes the conduct of randomized 10 studies in which patients are randomized to receive, or not receive, SARS-CoV-2 vaccination. 11

Future studies will need to examine the impact of single-dose vaccines (Janssen) on 12 surgical outcomes, as these patients were beyond the scope of the current study. Secondly, due to 13 limited number of events, we were unable to analyze elective surgeries separate from emergency 14 surgeries. However, we minimized the possibility of confounding by adjusting for ECI, ASA 15 class, CPT system, and case urgency. Finally, this analysis relied on administrative data, which is 16 influenced by patterns of coding within different institutions. 17

Our data show, at least for the variants that circulated early in the pandemic, in patients 20 who undergo surgery, that one vaccination provides more protection against COVID-19 related 21 adverse events than none, and two vaccinations provide more protection than one vaccination. 22

Postoperative pulmonary complications and mortality are significantly reduced in patients fully 23 or partially vaccinated before surgery, with fully vaccinated patients having the greatest 1 protection. Our analysis of VA data provides support for two doses of presurgical SARS-CoV-2 2 vaccination and ideally waiting two weeks after the second dose of before preforming surgery. 3

Where possible, patients should be encouraged to receive one, and when possible two doses of 4 COVID-19 vaccination prior to surgery. However, even a single dose of vaccine was associated 5 with reduced rates of postoperative COVID-19 infection and mortality. These data will allow 6 patients and surgeons to make an informed decision about delaying elective or urgent surgery to 7 achieve full vaccination, but additional research is needed to more clearly define the risks and 

of Disease Control and Prevention. COVID-19 Vaccinations in the United States

The Impact of Vaccination on Coronavirus 4 Disease 2019 (COVID-19) Outbreaks in the United States

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide

Mass Vaccination Setting

Covid-19: First doses of vaccines in Scotland led to a substantial fall in 10 hospital admissions

Meeting Briefing Document-FDA. 2020. 13 6. When You've Been Fully Vaccinated | CDC

COVID-19 Vaccination Associated with

Post-Operative SARS-CoV-2 Infection and Morbidity

Veterans Affairs Health Administration. U.S. Department of Veterans Affairs

Department of Veterans Affairs

Covid-19 Vaccine

Efficacy and Safety of the mRNA

CoV-2 Vaccine

Antibody response to first BNT162b2 dose in 14 previously SARS-CoV-2-infected individuals

Antibody Responses in Seropositive 17 Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

Antibody Responses after a Single Dose of 20 SARS-CoV-2 mRNA Vaccine